| Clustering of Metabolic Abnormalities Among Obese Patients and Mortality After Percutaneous Coronary Intervention. | |
| | |
MedLine Citation:
|
PMID: 21420054 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Although current literature demonstrates metabolic abnormalities are associated with mortality, obese patients who tend to have more metabolic abnormalities paradoxically have lower overall mortality rates compared to their normal-weight counterparts. In this study, we examined the prevalence of metabolic abnormality clustering and its relation to mortality in obese and normal-weight patients after percutaneous coronary intervention (PCI). Patients (n = 9,673) undergoing elective PCI from October 2003 through December 2006 at a single urban hospital were categorized by body mass index (BMI) levels of 18.5 to 24.9, 25.0 to 29.9, 30.0 to 34.9, and ≥35 kg/m(2) and by number of metabolic abnormalities possessed (hypertension, impaired fasting glucose/diabetes, triglycerides ≥150 mg/dl, high-density lipoprotein cholesterol < 40 mg/dl, and C-reactive protein ≥2.0 mg/L). All-cause mortality was assessed through June 30, 2007. Mean age of patients was 65.9 years and 66% were men. Prevalences of 4 or 5 metabolic abnormalities were 12%, 18%, 24%, and 31% in patients with BMI levels of 18.5 to 24.9, 25.0 to 29.9, 30 to 34.9, and ≥35 kg/m(2), respectively. In patients with BMI of 30.0 to 34.9 kg/m(2), hazard ratios (95% confidence intervals) for mortality associated with 2, 3, and 4 to 5 metabolic abnormalities versus 0 to 1 metabolic abnormality were 1.31 (0.79 to 2.17), 1.42 (0.83 to 2.43), and 2.39 (1.24 to 4.59), respectively. Analogous hazard ratios for patients with BMI ≥35 kg/m(2) were 1.94 (0.90 to 4.20), 1.44 (0.63 to 3.28), and 2.17 (0.91 to 5.18). All-cause mortality rates per 1,000 person-years were 55.5, 33.7, 28.3, and 33.8 in patients with BMI levels of 18.5 to 24.9, 25 to 29.9, 30 to 34.9, and ≥35 kg/m(2), respectively. In conclusion, BMI levels of 25.0 to 29.9 and 30 to 34.9 kg/m(2) were associated with lower all-cause mortality after PCI. However, an increased number of metabolic abnormalities translated into increased all-cause mortality. |
| | |
Authors:
|
Sameer Bashey; Paul Muntner; Annapoorna S Kini; Ricardo Esquitin; Louai Razzouk; Shiny Mathewkutty; Rachel P Wildman; April P Carson; Michael C Kim; Pedro R Moreno; Samin K Sharma; Michael E Farkouh |
Related Documents
:
|
444654 - Fetal hemoglobin in polycythemia vera: cellular distribution in 50 unselected patients. 16117194 - Hypopituitarism and anemia: effect of replacement therapy with hydrocortisone and/or le... 15812074 - Recombinant human erythropoietin and overall survival in cancer patients: results of a ... 19545554 - Response to hydroxyurea in beta thalassemia major and intermedia: experience in western... 16611374 - Influence of specific nutrients on progression of atherosclerosis, vascular function, h... 9156144 - Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-17 |
Journal Detail:
|
Title: The American journal of cardiology Volume: - ISSN: 1879-1913 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Inc. All rights reserved. |
Affiliation:
|
The Mount Sinai Cardiovascular Institute, New York, New York. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A new protocol using sodium bicarbonate for the prevention of contrast-induced nephropathy in patien...
Next Document: Effect of Clinical Triggers on Positive Responses to Tilt-Table Testing Potentiated With Nitroglycer...